This site is intended for healthcare professionals only
LoginRegister
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatmentBristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in...
Sanofi Sarclisa approved in EUSanofi Dupixent approved in Japan for COPD
NPPA Revises Ceiling Price of Coronary StentsNPPA Revises Ceiling Price of Coronary Stents
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo...
AstraZeneca, Summit in discussions over USD 15 billion cancer drug licensing deal: ReportAstraZeneca Pharma India to discontinue manufacturing, marketing of angina drug from April 1
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialNovartis radioligand therapy Pluvicto gets USFDA nod for expanded indication
Lupin three senior executives to retireLupin three senior executives to retire in 2 days
AstraZeneca Imfinzi gets USFDA priority reviewUSFDA approves Sanofi Qfitlia for hemophilia A or B with or without inhibitors
Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide, and TramadolDrug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin,...
Sun Pharma, Incyte settle dispute over LEQSELVIBioNTech vs CureVac: European Patent Office declares CureVac mRNA patent valid
Pune Pharmacist Loses Rs 95 Lakh in Medical Store DealProcure medicines from Jan Aushadhi Kendras: Delhi Govt mandates its hospitals
Sun Pharma Gets SEC Nod to Begin Phase III Trial of Cough Drug GefapixantSun Pharma investee firm Lyndra Therapeutics ceased operations
X